Tertiary lymphoid structure transcriptomic signatures show limited and cohort-dependent value for predicting axillary nodal involvement in oestrogen receptor-positive luminal breast cancer

Anti-Cancer Drugs · Published 2026-07-28 · DOI 10.1097/cad.0000000000001836

Free full text

Authors (4)

Tao Wang, Yi Zhang, Xinhua Yang, Peng Qi

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Wang, T., Zhang, Y., Yang, X., et al. (2026). Tertiary lymphoid structure transcriptomic signatures show limited and cohort-dependent value for predicting axillary nodal involvement in oestrogen receptor-positive luminal breast cancer. Anti-Cancer Drugs. https://doi.org/10.1097/cad.0000000000001836

Related articles

• Temozolomide-based therapy may remodel the tumor microenvironment and enhance immunotherapy sensitivity in advanced leiomyosarcoma · Anti-Cancer Drugs · 2026 · Same journal
• Activation of the caspase-1/gasdermin D pathway via α-linolenic acid-mediated GPR120 signaling induces pyroptosis and suppresses ovarian cancer tumor growth · Anti-Cancer Drugs · 2025 · Same journal
• Growth differentiation factor-11 inhibits the progression of acute myeloid leukemia and increases chemosensitivity by inhibiting cathepsin S · Anti-Cancer Drugs · 2026 · Same journal
• Treatment of HRD-positive elderly ovarian cancer patient: a case report · Anti-Cancer Drugs · 2025 · Same journal
• Prochlorperazine inhibits the proliferation of hepatocellular carcinoma cells by promoting phosphorylation of β-catenin · Anti-Cancer Drugs · 2026 · Same journal
• Successful treatment with erlotinib plus ramucirumab in a patient with non-small-cell lung cancer harboring EGFR exon 20 insertion mutation · Anti-Cancer Drugs · 2025 · Same journal
• Dual checkpoint inhibition achieves successful treatment of diffuse bilateral lung metastasis in giant advanced liver cancer: a case report · Anti-Cancer Drugs · 2026 · Same journal
• Akt inhibitor-IV in estrogen receptor-positive breast cancer cells: cytotoxic, apoptotic, transcriptional, and in-silico comparison with tamoxifen · Anti-Cancer Drugs · 2026 · Same journal
• SENP3-mediated deSUMOylation stabilizes programmed death-ligand 1 to promote immune evasion in hepatocellular carcinoma · Anti-Cancer Drugs · 2026 · Same journal
• Histone lactylation promoted colorectal cancer progression by enhancing tumor necrosis factor transcription and served as a diagnostic biomarker · Anti-Cancer Drugs · 2025 · Same journal